Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies
Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry’s largest manufacturers of these components globally Builds on company’s 30 years’ CDMO experience with multi-step, complex, and highly potent compounds Merck, a leading science and technology company, announced that its Life Science business sector has doubled its high-potent […]
